Prognostic Significance of Potential Immune Checkpoint Member HHLA2 in Human Tumors: A Comprehensive Analysis

Immunological checkpoint inhibitors have been immensely successfully applied in the treatment of cancer, however, a portion of tumor patients can't benefit from checkpoint therapy. The low PD-1/CTLA-4 positive rate and involvement of multiple immunosuppressive pathways are thought to be one of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ben, Ran, Zhujie, Liu, Mengmeng, Ou, Yunsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644528/
https://www.ncbi.nlm.nih.gov/pubmed/31379814
http://dx.doi.org/10.3389/fimmu.2019.01573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644528/
https://www.ncbi.nlm.nih.gov/pubmed/31379814
http://dx.doi.org/10.3389/fimmu.2019.01573

Ejemplares similares